Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2- metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis. [electronic resource]
Producer: 20170117Description: 414-23 p. digitalISSN:- 1941-837X
- Antineoplastic Agents -- economics
- Antineoplastic Combined Chemotherapy Protocols -- economics
- Breast Neoplasms -- drug therapy
- Everolimus -- economics
- Female
- Health Expenditures -- statistics & numerical data
- Health Services -- economics
- Humans
- Insurance Claim Review -- statistics & numerical data
- Kaplan-Meier Estimate
- Neoplasm Metastasis
- Receptor, ErbB-2
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.